Hospital Universitario Fundacion Alcorcon — Clinical Trial Site

92 Registered trials

35 Currently recruiting

Organisation

Hospital Universitario Fundacion Alcorcon

Location

Alcorcon, Spain

Identifier

ORG-100028556

Address

Calle Budapest 1, 28922, Spain

Departments

#2312:servicio de neurología
3129: medicina interna
7008: Oncología
Alergología
Allergology
Cardiología
Cirugía
Departamento de Aparato Digestivo
Departamento de Psiquiatria. Sala 6. Puerta 19.
Department of Urology
Dermatology
Dermatology Department
Digestive
Endocrinology and metabolism
Gastroenterología
Gastroenterology
Hematology
Hospital Fundacion Alcorcon
Infectious Diseases and Research Unit
Internal medicine
Medical Oncology
Medicina interna
N/A
Nefrology
Nephrology
Neumología
Neurologia
Neurology
Neurology Unit
None
Oncología
Oncología Médica
Oncology
Oncology Service
Pediatría
Pneumology
Prevention and Occupational Health Service
Psiquiatría
Psychiatry
Psyquiatry
Servicio de digestivo
Servicio de Hematología
Servicio de Neurologia
Servicio de Oncología Médica
Urología
Urology

Clinical trials at this site (92)

Search interface

Dose-response characterization of VER-01 in the treatment of patients with chronic non-specific low back pain Ended

2023-507358-34-00 For the treatment of patients with chronic non-specific 4 2024-02-13
MK-0616-013 Ended

2022-502777-42-01 Hypercholesterolemia 5 2024-01-16
Efficacy and Safety of JNJ-77242113 in Participants with Moderately to Severely Active Ulcerative Colitis Ended

2023-504673-20-00 Ulcerative Colitis 4 2023-12-06
A Clinical Study that will measure how well SEP-363856 works and how safe it is in adults with Generalized Anxiety Disorder Ended

2022-502077-42-00 generalised anxiety disorder 10 2023-09-14
Ecopipam Tablets to Study Tourette’s Disorder in Children, Adolescents and Adults (D1AMOND) Ended

2023-503494-38-00 Tourette’s Disorder 5 2023-07-20
A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants with Advanced/Metastatic Non-Sq… Ended

2022-500608-23-00 Previously Untreated MET Amplified Locally Advanced/Met 4 2023-04-06
Phase 3 Study of Bepirovirsen in Nucleos(t)ide Analogue-treated Participants with Chronic Hepatitis B (B-Well 2) Ended

2023-504238-23-00 Hepatitis B, Chronic 5 2023-01-17
Clinical Trial to Evaluate the Safety and Appropriateness of Switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir A… Ended

2024-511951-16-00 HIV 6 2022-08-30
Cohort study of human mpox virus disease Ended

2022-501132-42-00 Monkeypox virus disease 6 2022-08-02
Advanced hormone receptor-positive/HER2-negative/HER2-Enriched breast cancer Ended

2023-508828-35-01 Patients with advanced hormone receptor-positive/HER2- 5 2022-03-28
DTG/3TC vs BIC/FTC/TAF maintenance therapy in people living with HIV: an open-label randomized clinical trial Ended

2024-515167-56-00 HIV 11 2021-06-22
Non-inferiority study of GSK3511294 (depemokimab) compared with mepolizumab or benralizumab in participants with severe asthma with an eosin… Ended

2023-510230-84-00 Severe asthma with an eosinophilic phenotype 5 2021-05-28
A clinical trial which runs in multiple countries and aims to evaluate the long-term safety and tolerability of the investigational product … Ended

2024-512123-37-00 Parkinson's disease 5 2021-05-27
A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab… Ended

2023-507317-10-00 Locally advanced, unresectable, or metastatic non small 5 2021-05-10
A trial to learn how well darolutamide plus androgen deprivation therapy (ADT) works in comparison to placebo plus ADT in men with prostate … Ended

2022-502244-12-00 Metastatic hormone-sensitive prostate cancer (mHSPC) 5 2021-02-22
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev… Ended

2022-502361-15-00 Moderate-to-Severe Plaque Psoriasis 5 2019-12-12
A Phase 4 study to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged release (SPD503) in Children and Adolescents aged 6 … Ended

2022-502630-71-00 Attention-deficit/hyperactivity disorder (ADHD) 6 2019-11-20
A Phase 3 Study Comparing Daratumumab, VELCADE (bortezomib), Lenalidomide, and Dexamethasone (D-VRd) with VELCADE, Lenalidomide, and Dexamet… Ended

2023-507312-13-00 Multiple Myeloma 5 2018-11-15
Study to Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as an Adjunctive Treatment for Schizophrenia Ended

2022-502233-25-00 Schizophrenia 5
Simvastatin in the Prevention of Recurrent Pancreatitis, a Triple Blind, Randomized Controlled Trial. Ended

2024-513188-17-03 Recurrent pancreatitis 6